Infinity Diagnostics in Ventnor shut down soon after being raided by the FBI in December 2020. The lab was accused of administering finger-stick antibody tests that were not actually capable of doing what it said.

In the wake of the lab’s closure, officials urged any patients to get re-tested for COVID-19 as soon as possible.

On November 5, a class action settlement against Infinity Diagnostics received preliminary court approval. Stephen Denittis, an attorney representing the plaintiffs in the lawsuit, said that around 400 patients should be entitled to repayment for the alleged fraudulent tests they received.

“The fact that a lab would potentially, allegedly to fraud people to make money off of this we thought was really egregious,” Denittis told NBC New York.

The proposed settlement currently working its way through the court calls for patients with a receipt for their test to get a full $75 refund from Infinity Diagnostics. Other patients who do not have a receipt can receive up to $37.50.

No charges have been filed in the case, according to the U.S. Attorney’s office.

New Jersey couple Thomas and Bonnie Young were among the patients included in the lawsuit.

“I think they took advantage of people fully,” Bonnie Young told NBC New York.

“It was kind of shady, you know, the way the whole thing was run,” Thomas Young added.

The next court date scheduled for the case is on January 21 in which a judge could potentially make a decision on the settlement. If so, Denittis estimated that payments could be sent out to patients within 60-90 days.

Infinity Diagnostics has not been responsive to questions from the press about its alleged actions. According to the proposed settlement, the company currently denies any wrongdoing. Denittis explained that Infinity’s argument is that it was not aware that its tests were not valid.

“They maintained that…they thought it was an official test,” Denittis said. “They didn’t think they were, they alleged they weren’t doing this on purpose.”

Newsweek reached out to Infinity Diagnostics and Denittis for comment.

Last month, it was reported that a number of at-home COVID tests manufactured by Ellume were recalled after they were found to offer incorrect false-positive results.

“In recent weeks, we noted an increased chance that Ellume COVID-19 Home Tests from specific lots may provide an incorrect positive result,” said the company in a statement. “Following a thorough investigation, we isolated the cause and confirmed that this incidence of false positives is limited to specific lots.”

Sean Parsons, Ellume’s CEO and founder, added: “At Ellume, we understand that trust is central to fulfilling our purpose as a company, and we recognize that this incident may have shaken the confidence of some of those who trusted Ellume to help them manage their health and to take back a bit of control of their lives during this pandemic.”